Mediators of inflammation in response to air pollution: A focus on ozone and nitrogen dioxide - A 'concerted action' project in the eu biomed2 programme for promoting research that meets the public health needs of European citizens

Journal of the Royal College of Physicians of London

Volumn 30, Issue 1, 1996, Pages 61-66

  Krishna, M T ^a   Springall, D R ^b   Frew, A J ^a   Polak, J M ^b   Holgate, S T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN DIOXIDE; OZONE;

AIR POLLUTION; ASTHMA; HUMAN; HYPERSENSITIVITY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW;

AIR POLLUTION; ASTHMA; HUMANS; HYPERSENSITIVITY; NITROGEN DIOXIDE; OZONE; RESPIRATORY TRACT DISEASES; RESPIRATORY TRACT INFECTIONS;

EID: 0029690847     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. A first report to the RAC Foundation for Motoring and the Environment. Cars and the environment: a view to the year 2020. London: RAC Foundation, 1992.
2. Parliamentary Office of Science and Technology. Breathing in our cities-urban air pollution and respiratory health. London: HMSO 1994.
3. Sears MR. Epidemiology of asthma. In: O'Byrne PM (ed). Asthma as an inflammatory disease. New York: Dekker, 1990:15-48 .
4. Lippert FW, .Morris SC. Air pollution: cost benefit assessment. Science 1991;253:606-9.
5. Imai M, Yoshida K, Kitabake M. Mortalilty from asthma and chronic bronchitis associated with changes in sulphur dioxide air pollution. Arch Environ Health 1986;41:29-35.
6. Schmitzberger R, Rhomberg K, Buchele H, et al. Effects of air pollution on the respiratory tract of children. Paediatr Pulmonol 1993;15:68-74.
7. Hazucha MJ. Relationship between ozone exposure and pulmonary function changes. J Appl Physiol 1987;62:1671-80.
8. Silverman F, Folinsbee LJ, Barnard J, Shepherd RJ. Pulmonary function changes in ozone - interaction of concentration and ventilation, J Appl Physiol 1976;41 (6) :859-64.
9. Hazucha MJ, Bates DV, Bromberg PA. Mechanism of action of ozone on human Jung. J Appl Physiol 1989;67:1535-41.
10. Folinsbee LJ, Hazucha MH. Persistence of ozone induced changes in lung function and airway responsiveness. In: Schneider T, Lee SD, Wolters GJR, Grant LD (eds). Atmospheric ozone research and its policy implications. Amsterdam: Elsevier Science Publishers BV, 1989;523-32.
11. UK Advisory Group on Medical Aspects of Air Pollution Episodes. First report ozone. London: HMSO, 1991.
12. McDonnell WF, Chapman RS, Leigh MW, Strope GL, Collier AM. Respiratory responses of rigorously exercising children to 0.12ppm ozone exposure. Am Rev Respir Dis 1985;132:875-9.
13. Dimeo MJ, Glenn MG, Holtzmann MJ, et al. Threshold concentration of ozone causing an increase in bronchial reactivity in humans and adaptation with repeated exposure. Am Rev Respir Dis 1981;124:245-8.
14. Krishna MT, Mudway I, Kelly FJ, Frew AJ, Holgate ST. Ozone, airways and allergic airways disease. Clin Exp Allergy 1995 (in press).
15. Koren PS, Devlin RB, Graham DE, et al. Ozone induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989;139:407-15.
16. Devlin RB, McDonnell WF, Mann R, et al. Exposure of humans to ambient ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol 1991;4:72-81.
17. Schelegle ES, Siefkin AD, McDonald R. Time course of ozone induced neutrophilia in normal subjects. Am Rev Respir Dis 1991;141:1353-8.
18. Aris RM, Christian D, Hearne PQ, et al. Ozone induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis 1993;148:1363-72.
19. Mustafa MG. Biochemical basis of ozone toxicity. Free Rad Biol Med 1990;9:245-65.
20. Kelly FJ, Mudway I, Krishna MT, Holgate ST. The free radical basis of air pollution: focus on ozone. Respir Med 1995;89: 647-56.
21. Konings AWT. Mechanisms of ozone toxicity in cultured cells. I. Reduced clonogenic ability of polyunsaturated fatty acid-supplemented fibroblasts. Effect of vitamin E. J Toxicol Environ Health 1986;18:491-7.
22. Van-Der-Zee J, Tijssen-Christianse K, Dubbleman TM, Van-steneick J. The influence of human red blood cells. Comparison with other mechanisms of oxidative stress. Biochem Biophys Acta 1987;924:111-8.
23. Seltzer J, Bigby G, Stulberg M, Holtzmann MJ, Nadel JA. Ozone induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 1986;60:1321-6.
24. 2a in the airways of human subjects. Am J Respir Cell Mol Biol 1993;9:568-72.
25. Schelegle ES, Adams WC. Siefkin AD. Indomethacin pretreatment reduces ozone induced pulmonary function decrements in human subjects. Am Rev Respir Dis 1987;136:1350-4.
26. Ying RL, Gross KB, Terzo TS, Eschenbacher WL. Indomethacin does not inhibit the ozone induced increase in bronchial responsiveness in human subjects. Am Rev Respir Dis 1990; 142:817-21.
27. Alexis N, Silvermann F, Tarlo S, Covey P. Effects of indomethacin on acute ozone exposure in asthmatics. Am J Respir Crit Care Med 1995;151:A28(abstract).
28. Bottei GM, Devlin RB, Bromberg PA, Peden PB. The effect of corticosteroids on lower airway inflammation and pulmonary function after ozone exposure. Am J Respir Crit Care Med 1995; 151:A28(abstract).
29. Driscoll KE, Hassenbein D, Carter J, et al. Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts and epithelial cells and in rat tissue after ozone exposure. Am J Respir Cell Mol Biol 1993;8:311-8.
30. Aris R, Ferrando R, Chen LC, Christian D, Balmes JR. Increased expression of ICAM on bronchial endothelium after acute exposure to ozone. Am J Respir Crit Care Med 1995;151:A23(abstract).
31. Baeuerle PA, Henkel T. Function and activation of NFκB in the immune system. Ann Rev Immunol 1994;12:141-79.
32. Manning AM, Anderson DC. Transcription factor NFκB: an emerging regulator of inflammation. In: Bristol JA (ed). Annual reports in medicinal chemistry. San Diego: Academic Press, 1994;235-44.
33. Marui N, Offerman MK, Swerlick R, et al. Vascular cell adhesion molecule-l gene transcription and expression are regulated through an anti-oxidant sensitive mechanism in human vascular endothelial cell, J Clin Invest 1993;92:1866-74.
34. Malek FY, Utell MJ, Looney RJ, et al. Does exposure to ozone induce an acute systemic phase response in humans. Am J Respir Crit Care Med 1995;151:A27(abstract).
35. McKinney WJ, Dreher KL, Jascot RH, Baumann H, Costa DL. The role of IL-6 in ozone induced tolerance. Am J Respir Crit Care Med 1994;149:A156(abstract).
36. Solway J, Leff A. Sensory neuropeptides and airway function, J Appl Physiol 1991;71:2077-87.
37. Foster W, Costa D, Langenback E. Ozone exposure alters tracheobronchial mucociliary function in humans. J Appl Physiol 1987;63:996-1002.
38. Fuller RW, Maxwell DL, Dixon CMS, et al. Effect of substance P on cardiovascular and respiratory function in human subjects. J Appl Physiol 1987;62:1473-9.
39. Molfino NA, Wright SC, Ketz I, et al. Effect of low concentrations of inhaled allergen responses in asthmatic patients. Lancet 1991;338:199-203.
40. White MC, Etzel RA, Wilcox WD, Lloyd C. Exacerbations of childhood asthma and ozone pollution in Atlanta. Environ Res 1994;65:56-68.
41. Cody RP, Weisel CP, Beinbaum G, Lioy PJ. The effect of ozone associated with summertime photochemical smog on the frequency of asthma visits to hospital emergency departments. Environ Res 1992;58:184-94.
42. Bates DV, Baker-Anderson M, Sitzo R. Asthma attack periodicity: a study of hospital emergency visits to Vancouver. Environ Res 1990;51:51-70.
43. Bascom R, Nacleiro RM, Fitzgerald TK, Kagey-Sabotka A, Proud D. Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects. Am Rev Respir Dis 1990;142:594-601 .
44. McBride DE, Koenig JQ, Luchtel DL, Williams PV, Henderson Jr WR. Inflammatory effects of ozone in the upper airways of subjects with asthma. Am J Respir Crit Care Med 1994;149:1192-7.
45. Schroeder JM, Mrowietz U, Morita E, Christophers E. Purification and partial biochemical characterisation of human monocyte derived neutrophil-activating peptide that lacks IL-1 activity. J Immunol 1987;139:3474-83.
46. Thelen M, Peveri P, Kernen P, Von Tscharner V, Walz A, Baggiolini M. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 1988;2:2702-6.
47. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptidel/interleukin-8, a novel cytokine that activates neutrophils. J Clin invest 1989;84:1045-9.
48. Kehrl HR, Vincent LM, Kowalsky RJ, et al. Ozone increases respiratory permeability in humans. Am Rev Respir Dis 1987; 135:1124-8.
49. Helleday R, Sandstrom T, Stjernberg N. Differences in bronchoalveolar cell response to nitrogen dioxide between smokers and non-smokers. Eur Respir J 1994;7:1213-20.
50. Sandstrom T, Helleday R, Blomberg A, Stjernberg N, Henderson R. Repeated exposure to nitrogen dioxide affects hyaluran, myeloperoxidase and methyl histamine in BAL fluid. Am J Respir Crit Care Med 1995;151:A284(abstract).
51. Sandstrom T, Stjernberg N, Elund A, et al. Inflammatory cell response in bronchoalveolar lavage fluid after nitrogen dioxide exposure: a dose response study. Eur Respir J 1991;4:332-9.
52. Jorres R, Nowak D, Grimminger F, et al. The effect of 1ppm nitrogen dioxide on bronchoalveolar lavage cells and inflammatory mediators in normal and asthmatic subjects. Eur Respir J 1995;8:416-24.
53. Dooley MM, Pryor WA. Free-radical pathology: inactivation of alpha-1-protease inhibitor by products from the reaction of nitrogen dioxide with hydrogen peroxide and the aetiology of emphysema. Biochem Biophys Res Commun 1982;106:981-7.
54. Pryor WA, Dooley MM, Church DF. Inactivation of human alpha-1-proteinase inhibitor by gas phase cigarette smoke. Biochem Biophys Res Commun 1984;122:676-81.
55. Devalia JL, Campbell AM, Sapsford RS, et al. Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial cells in vitro. Am J Respir Cell Mol Biol 1993;9:271-8.
56. Kienast K, McKinnon KP, Carter JD, Reed W, Devlin RB. Nitrogen dioxide exposure of human airway epithelial cells in vitro increases steady state concentrations of inflammatory mediator mRNAs. Am J Respir Crit Care Med 1995;151:A284 (abstract).
57. 2) induces a decrease in calcitonin gene-related peptide (CGRP) and tachykinin immunoreactivity in guinea pig peripheral airways. Am J Respir Cell Mol Biol (in press).
58. Dijkstra L, Houthuijs D, Brunekreef B, Akkerman I, Boleij JS. Respiratory health effects of indoor environment in a population of Dutch children. Am Rev Respir Dis 1990;142:1172-8.
59. Samet JM, Lambert WE, Skipper BJ, et al. Nitrogen dioxide and respiratory illness in infants 1993;148:1258-65.
60. Hasselblad V, Eddy DM, Kotchmar DJ. Synthesis of environmental evidence: nitrogen dioxide epidemiological studies. J Air Wast Manage Assoc 1992;42:662-71.
61. Sandstrom T, Helleday R, Bjermer L, Stjernberg N. Effects of repeated exposure to 4ppm nitrogen dioxide on bronchoalveolar lavage fluid lymphocyte subjects and macrophages in healthy men. Eur Respir J 1995;5:1092-6.
62. Frampton MW, Smeglin AM, Roberts NJ, et al. Nitrogen dioxide exposure in vivo and human alveolar macrophage interaction of influenza virus in vitro. Env Res 1989;48:179-92.